Female doctor asking questions to prostate cancer patient

No need to rush localised prostate cancer treatment, researchers say

Men with localised prostate cancer had the same survival rates regardless of whether they received radiotherapy, surgery or just active monitoring, a new study has revealed.

The research, published in The New England Journal of Medicine, was led by the universities of Oxford and Bristol, with its findings being presented to the European Association of Urology Congress in Italy.

The researchers found that those who were actively monitored and received regular cancer checks were more likely to have their cancer grow or spread, compared to men undergoing surgery or radiotherapy.

Those who had radiotherapy or surgery found that their side effects of incontinence and impotence could persist up to 12 years – much longer than originally thought.

Despite all this, the trial found that 97% of the men taking part survived 15 years after their diagnosis, irrespective of what treatment they received. Study participants from all three groups also reported similar quality of life.

The trial’s Chief Investigator, Professor Freddie Hamdy, said: “This is very good news. Most men with localised prostate cancer are likely to live for a long time, whether or not they receive invasive treatment and whether or not their disease has spread, so a quick decision for treatment is not necessary and could cause harm.

“It’s also now clear that a small group of men with aggressive disease are unable to benefit from any of the current treatments, however early these are given. We need to both improve our ability to identify these cases and our ability to treat them.”

Researchers also discovered some flaws in the current methods of predicting which specific cases of prostate cancer are likely to grow and spread quickly – initially, of all the men recruited to the study, 77% were deemed low risk, but following a reassessment using more modern techniques, a far greater proportion were considered intermediate risk, with approximately 30% of the patients having their cancer spread from the prostate already.

Crucially though, the researchers say their results show treatment decisions for low and intermediate risk localised prostate cancer don’t need to be rushed.

Professor Hamdy added: “It’s clear that, unlike many other cancers, a diagnosis of prostate cancer should not be a cause for panic or rushed decision making. Patients and clinicians can and should take their time to weigh up the benefits and possible harms of different treatments in the knowledge that this will not adversely affect their survival.”

The research was funded by the National Institute for Health and Care Research. Read the 15-year outcomes here and the 12-year results here.

National Health Executive, Jan/Feb, Cover

NHE Jan/Feb 22

The pioneering programmes aimed at solving the NHS workforce pressures - starting at the top

This issue highlights the latest topics within the health sector, from pioneering programmes aimed at solving the NHS workforce pressures, treatment to slow the progression of Parkinson's disease, how the UK is leading the way in cancer research & more!


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all